Compare BMY & COP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BMY | COP |
|---|---|---|
| Founded | 1887 | 1917 |
| Country | United States | United States |
| Employees | 32500 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.7B | 136.5B |
| IPO Year | N/A | 2005 |
| Metric | BMY | COP |
|---|---|---|
| Price | $58.50 | $133.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 22 |
| Target Price | $61.81 | ★ $118.64 |
| AVG Volume (30 Days) | ★ 9.6M | 9.5M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.24% | 2.52% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.35 |
| Revenue | N/A | ★ $58,944,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.21 |
| P/E Ratio | ★ $17.26 | $20.99 |
| Revenue Growth | N/A | ★ 7.67 |
| 52 Week Low | $42.52 | $79.88 |
| 52 Week High | $62.89 | $133.55 |
| Indicator | BMY | COP |
|---|---|---|
| Relative Strength Index (RSI) | 46.27 | 81.23 |
| Support Level | $53.88 | $90.89 |
| Resistance Level | $62.47 | N/A |
| Average True Range (ATR) | 1.18 | 2.85 |
| MACD | -0.20 | 0.79 |
| Stochastic Oscillator | 43.40 | 94.46 |
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
ConocoPhillips is a US-based independent exploration and production firm. Its operations are primarily in Alaska and the Lower 48, with footprints in Canada, Europe, Asia-Pacific, the Middle East, and Africa. It also has substantial integrated LNG production and marketing activities across geographies.